SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MEDIBIO LIMITED (MEB)

Listed on ASX ( $0.335    -0.015    -4.286%)

Former (or subsequent) names

 FROMTO
MEDIBIO LIMITED01/12/2014
BIOPROSPECT LIMITED01/12/2014

Shareholder links

 

REGISTRY:

Computershare Investor Services, Level 11 172 St Georges Terrace Perth WA 6000

Tel : +61 7 3237 2100 or 1300 552 270
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

Address: Suite 302, Level 3 17 Castlereagh Street Sydney NSW 2000
Tel:  +61 2 9299 9580 Fax: +61 2 9299 9501

Date first listed: 29/01/2001
Company Secretary: Robert Lees
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Development of diagnostic heart rate variability technology for mental health diagnosis
we understand that on or about this date the company consolidated its shares 1 for 10020/03/2015
The suspension of trading in the securities of Medibio Limited (the "Company") will be lifted immediately following receipt of an announcement in relation to an agreement with John Hopkins Hospital. Security Code: MEB01/12/2014
name changed from Bioprospect Limited01/12/2014

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/07/2017Peter Carlisle5,500 $0.373$2,053
    18/04/2017Jack Cosentino100,000 $0.370$37,000
    04/04/2017Jack Cosentino100,000 $0.370$37,000
    06/03/2017Kris Knauer100,000 $0.316$31,625
    20/06/2014Claude Solitario1,987,009 $0.004$6,955

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Chris IndermaurNon Exec Chairman02/04/2015
    Adam DarkinsDeputy Chairman19/07/2017
    Jack CosentinoManaging Director, CEO16/02/2017
    Brian MowerCFO24/04/2017
    Franklyn PrendergastNon Exec Director27/01/2016
    Andrew MaxwellNon Exec Director01/02/2017
    Kris KnauerExecutive Director, CFO02/07/2014
    Patrick KennedyDirector04/07/2017
    Michael PhelpsDirector05/06/2017
    Peter CarlisleAlternate Director05/06/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Robert LeesCFO28/09/201224/04/2017
    James CampbellNon Exec Director07/09/201430/09/2016
    Vince FayadNon Exec Chairman29/04/201407/04/2015
    Silvi ElkhouriNon Exec Director15/11/201308/09/2014
    Claude SolitarioExecutive Director29/04/201408/09/2014
    Peter MayNon Exec Director01/11/200830/06/2014
    Benjamin CooperExecutive Director10/04/201229/04/2014
    Winton WilleseeChairman, Non Exec Director16/09/201115/11/2013
    Peter PellegrinoManaging Director01/11/200919/11/2012
    Colin JohnstonCFO01/03/200428/09/2012
    Jacob KhouriNon Exec Director16/02/201118/09/2012

    Date of first appointment, title may have changed.